首页RGEDF • OTCMKTS
Gedeon Richter Ord Shs
$27.17
1月15日, GMT-5 00:20:13 · USD · OTCMKTS · 免责声明
股票在美国上市的证券
昨日收盘价
$27.17
年度波幅
$24.01 - $29.58
市盈率
-
股息率
-
CDP 气候变化得分
D
市场资讯
财务信息
损益表
收入
净收入
(HUF)2024年9月年同比变化
收入
2167.30亿14.95%
经营支出
946.86亿10.59%
净收入
370.60亿-32.07%
净利润率
17.10-40.89%
每股收益
息税折旧摊销前利润
763.89亿23.89%
有效税率
19.13%
总资产
负债总额
(HUF)2024年9月年同比变化
现金及短期投资
749.87亿-29.24%
总资产
1.49万亿9.53%
负债总额
2588.34亿-1.37%
权益总额
1.23万亿
发行在外的股份
1.83亿
市净率
0.00
资产回报率
10.29%
资本回报率
11.59%
现金净变动
(HUF)2024年9月年同比变化
净收入
370.60亿-32.07%
来自运营的现金
675.52亿56.30%
投资现金
-136.88亿54.12%
融资现金
-366.96亿-409.23%
现金净变动
171.18亿-34.71%
自由现金流
131.87亿1,594.12%
简介
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries. Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange. Richter sells products for the central nervous system, women's health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901. Wikipedia
成立时间
1901
员工数量
11,603
一探究竟
搜索
清除搜索内容
关闭搜索框
Google 应用
主菜单